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Background: Participation rates of lifestyle programs among type 2 diabetes mellitus (T2DM) patients are less than
optimal around the globe. Whereas research shows notable delays in the development of the disease among
lifestyle program participants. Very little is known about the relative importance of barriers for participation as well
as the willingness of T2DM patients to pay for participation in such programs. The aim of this study was to identify
the preferences of T2DM patients with regard to lifestyle programs and to calculate participants’ willingness to pay
(WTP) as well as to estimate the potential participation rates of lifestyle programs.
Methods: A Discrete Choice Experiment (DCE) questionnaire assessing five different lifestyle program attributes was
distributed among 1250 Dutch adults aged 35–65 years with T2DM, 391 questionnaires (31%) were returned and
included in the analysis. The relative importance of the program attributes (i.e., meal plan, physical activity (PA)
schedule, consultation structure, expected program outcome and out-of-pocket costs) was determined using
panel-mixed logit models. Based on the retrieved attribute estimates, patients’ WTP and potential participation rates
were determined.
Results: The out-of-pocket costs (β = −0.75, P < .001), consultation structure (β = −0.46, P < .001) and expected
outcome (β = 0.72, P < .001) were the most important factors for respondents when deciding whether to participate
in a lifestyle program. Respondents were willing to pay €128 per year for individual instead of group consultation
and €97 per year for 10 kilograms anticipated weight loss. Potential participation rates for different lifestyle-program
scenarios ranged between 48.5% and 62.4%.
Conclusions: When deciding whether to participate in a lifestyle program, T2DM patients are mostly driven by low
levels of out-of-pocket costs. Thereafter, they prefer individual consultation and high levels of anticipated outcomes
with respect to weight loss.
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Participation rates of lifestyle programs among type 2
diabetes mellitus (T2DM) patients are less than optimal
around the globe [1,2]. Yet, there appears to be notable
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reproduction in any medium, provided the ordifferent lifestyle programs [1–5]. Driven by these re-
sults, combined with the increasing prevalence of T2DM
and high disease-specific mortality rates [6,7], lifestyle
interventions have been included in standardized care
protocols for the treatment of T2DM patients in several
countries [8–10]. However, in general, the participation
rates of such lifestyle programs among T2DM patients
are unsatisfactory, ranging from 20-70% of those eligible
for such programs [1,2,11]. Suboptimal participation rates
are especially worrisome among the growing population
of T2DM patients aged 35–65 years. Lifestyle changesl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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to have a greater and more long-term impact on disease
progress than among older T2DM patients [12]. More-
over, these relatively young T2DM patients suffer less
from serious diabetes-related physical or medical restric-
tions [13,14] or from other chronic diseases or disabilities
[15,16]. Therefore, younger T2DM patients are relatively
suitable candidates for participation in a lifestyle program.
In order to obtain a better insight into the motives of
T2DM patients for participating in lifestyle interven-
tions, various studies were conducted that resulted in an
extensive list of barriers for participation in lifestyle inter-
ventions as reported by T2DM patients [17–21]. However,
very little is known about the relative importance of such
factors for these patients, while it seems reasonable to as-
sume that not all of the factors are of equal importance in
the decision-making process regarding the participation in
a lifestyle program. Previous research has shown that this
also applied with regard to lifestyle programs in other tar-
get populations [22–25].
A second omission in many studies on the willingness
to participate in lifestyle programs is that the costs of
lifestyle programs are often not included. If lifestyle in-
terventions were to be implemented in ‘real life’, partici-
pants in such programs would have to pay at least part
of the program costs out-of-pocket. Whereas participa-
tion in programs within a research setting tends to be
free of charge. Taking into consideration that these pro-
grams need to be (partly) financed by the participants, it
is worthwhile to examine the amount of money that po-
tential participants would be willing to pay. Previous re-
search among a non-diabetic population showed that the
582 individuals at a high risk of developing T2DM were
willing to pay out-of-pocket for a lifestyle intervention
[23]. These rates varied between $63 and $5 per month
for a three-year course depending on the diet restrictions,
hours of exercise, hour of counseling, use of medication,
the goal that was set with respect to weight loss and the
percentage expected reduction in T2DM risk [23].
Once we have obtained a better insight into and know-
ledge of program-related factors that are crucial for the
participation of T2DM patients in these lifestyle programs
as well as for their willingness to pay (WTP), recommen-
dations can be made as to what type of program would
most likely be preferred by its potential users. These rec-
ommendations can be taken into account when develop-
ing new lifestyle programs, thus increasing their reach,
and hence their public health benefit.
The aim of this study was to identify the preferences
of diabetes type 2 patients for different characteristics of
lifestyle programs. Based on these preferences, partici-
pants’ willingness to pay (WTP) as well as the potential
participation rates of different lifestyle programs have
been assessed.Methods
Participants and recruitment
Within the Netherlands, generic diabetes care is arranged
in care groups. A care group is a legal entity formed by
multiple health care providers (however, these are often ex-
clusively general practitioners (GPs)) [26]. A random selec-
tion of care groups (per province of the Netherlands) was
contacted to distribute the questionnaire among T2DM
patients aged 35–65 years who were not suffering from
any serious diabetes-related complications (i.e., cardiovas-
cular diseases, nephropathy, retinopathy, neuropathy) and
who were registered with that care group. In total five care
groups, located within five different provinces of the
Netherlands, participated. These care groups distributed a
total number of 1250 questionnaires to all the eligible pa-
tients within their care groups, 391 (31.3%) of which were
completed and included in the analysis. Due to confidenti-
ality agreements with the care groups that distributed the
questionnaires, no reminder letters could be sent. As a re-
sult, there was no non-response information available to
empirically test whether responders differed from non-
responders with respect to their demographic and disease-
specific characteristics. The Dutch National Ethics Board
(Central Committee on Research involving Human Sub-
jects) concluded that formal testing by a medical ethical
committee was not necessary, as T2DM patients were only
required to complete an anonymous questionnaire once,
which is in accordance with the guidelines laid down in the
Declaration of Helsinki.
The mean age of the final study population was 57.2 years,
more than half of the respondents were male (57.4%), al-
most all respondents were Dutch nationals (94.1%), and
about half of the population (49.6%) completed higher sec-
ondary education or lower general professional education
(Coded ‘medium’ in Table 1). On average, the participants
were diagnosed with T2DM 6.1 years ago and they had a
mean HbA1c of 49.9 mmol/mol. Of all the respondents,
37.8% was overweight (indicated by a BMI between 25 and
30 kg/m2) and 41.1% was obese (indicated by a BMI higher
than 30 kg/m2). The majority of the respondents reported
no complications (78.3%) and no other chronic conditions
(99.7%). 19% of the respondents reported that they did not
use any form of medication, 67.2% reported that they used
glucose lowering medication in the form of pills, 4.6%
reported that they injected insulin, and 9.2% reported
that they used both. Almost all respondents (94.1%) re-
ported that their primary health care contact was their
GP and not a specialist in secondary care (e.g., an in-
ternist). Self-management measures were applied by ap-
proximately half of this population; 45.8% reported that
they monitored their HbA1c at home and 50.3% re-
ported that they keep a T2DM diary.
In total 47.2% of this population reported that they
considered lifestyle programs to be useful and 66.7%
Table 1 General characteristics and psychosocial determinants of the study population (n = 391)
Mean (SD) Percentage
Age (n = 385) 57.2 (6.4)
Gender (n = 390) Male 57.4
Educational level (n = 379) Low 31.1
Medium 49.6
High 19.2
Ethnicity (n = 390) Dutch 94.1
Duration of diabetes (years) (n = 382) 6.1 (5.5)
HbA1c (mmol/mol) (n = 101) 49.9 (16.6)
Primary health care contact (n = 187) GP 94.1
Medication (n = 390) None 19.0
Oral glucose lowering medication 67.2
Insulin 4.6
Both 9.2
Complications present (n = 303) 21.7
Chronic condition present (n = 390) 0.3




EQ5d score (n = 391) 0.91 (0.19)
Self-management (n = 386) monitoring HbA1c at home 45.8
Keeping a T2DM diary 50.3
What is your opinion concerning lifestyle programs in general? (n = 388) Very useful or useful 47.2
Not useful at all 2.6
Do you think you are able to complete a lifestyle program that endures
1 year, without dropping out? (n = 391)
Certainly or probably 33.5
Certainly not 18.2
Would your partner, friends and/or family support you if you would
participate in a lifestyle program? (n = 391)
Certainly or probably 66.7
Certainly not 4.9
Would you like to participate in a lifestyle program? (n = 391) Certainly or probably 22.6
Certainly not 19.4
*Respondents were categorized as underweight if their BMI < 20 kg/m2, normal weight if BMI 20–25 kg/m2, overweight if BMI 25-30 kg/m2 and obese if
BMI >30 kg/m2.
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port their participation in a lifestyle program, 33.5% felt
that they would be able to complete such a lifestyle
program and 22.6% would actually like to participate in
such a program (Table 1).
Discrete choice experiment
DCEs are becoming a frequently used tool in public health
research to estimate the average participation rates of inter-
ventions or medical treatments and to provide knowledge
about the components of the programs that determine the
participation rates [27,28]. The DCE methodology is based
on the Random Utility Theory and assumes that anyintervention or treatment can be described by its charac-
teristics (i.e., attributes; such as frequency of consultation).
The individual’s preference for an intervention or treat-
ment is dependent on the levels (e.g., weekly or monthly
consultation) of those attributes [27,28]. By varying the
levels of the attributes, different scenarios are constructed.
Respondents are provided with at least two scenarios (i.e.,
choice tasks) simultaneously, they then have to choose the
scenario that they prefer most. Each respondent is asked to
complete a series of such choice tasks. In the end, con-
clusions can be drawn regarding the components that
constitute an intervention that is most preferred by its
potential users.
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The attributes and levels included in the current study
were determined in a stepwise manner, which subse-
quently included a literature review, expert interviews and
focus group interviews with T2DM patients. First, a list of
barriers for participating in a lifestyle intervention by
T2DM patients was compiled based on previously pub-
lished literature [17–21]. Second, the list of barriers thus
obtained was discussed during expert interviews with a
physician, a dietician and a scientist with a specific interest
in diabetes care. These expert interviews were conducted
in order to [1] shorten the list of potential attributes and
[2] to ensure that the attributes and levels were consistent
with current practice. As a third step, four focus group in-
terviews were conducted with 24 T2DM patients in order
to ensure that [1] the most important attributes for the
decision-making process of T2DM patients were included
in the DCE and [2] proper levels were appointed to each
of the attributes. Focus group interviews were conducted
according to Krueger and colleagues [29]. This process led
to the inclusion of five attributes (meal plan, physical ac-
tivity (PA) schedule, consultation structure, expected out-
comes and out-of-pocket costs) with three levels (Table 2).
Based on the selected attributes and levels, NGene 1.0
(ChoiceMetrics, 2011) software was used to develop a
D-efficient design with 18 unique choice tasks [30,31].
To limit the burden of respondents, NGene divided these
18 choice tasks over two sets of nine choice tasks, each set
of nine choice tasks was disseminated among half of the
study population. Besides choosing one of the lifestyle pro-
grams presented, participants could also choose an opt-
out solution. This opt-out option was included because, in
real life, people can also choose not to participate in a life-
style program. Table 3 presents an example of a choiceTable 2 The attributes and levels that were included in this d
Attributes Level 1 Level 2
Meal plan: a plan, which describes the aims of the participants with res
of the program together with a coach
Flexible: primarily based on the
participants’ own initiatives and ideas
General: includes ge
healthy diet and pro
Physical activity (PA) schedule: a plan, which describes the aims of the
developed by the participants of the program together with a coach
Flexible: primarily based on the
participants’ own initiatives and ideas
General: includes ge
PA, and provides ex
Consultation structure: the composition of the consults with the coach
Individually Groups with 5 othe
Expected outcomes: the results, in terms of weight loss and physical fit
lifestyle program
No weight loss but feeling more
healthy
5 kilograms of weig
more healthy
Out-of-pocket costs: patients may have to pay (part) of the program co
75 euro per year 150 euro per yeartask as included in the questionnaire of this study. Before
completing these choice tasks, respondents were provided
with an extensive explanation of the meaning of all attri-
butes and levels as well as an explanation about how to
deal with a choice task, accompanied by an example. Every
choice task starts with the question: ‘Imagine that your GP
or nurse practitioner advises that you participate in a life-
style program for a period of one year. In which situation
would you prefer to participate, situation 1 or situation 2?
If you do not wish to participate in either of the situations,
you can tick the box “none”. A questionnaire containing
additional questions was added to the DCE, for further de-
tails on this questionnaire see Additional file 1.
The draft questionnaire was pilot tested among a sub-
group (n = 20) of the study population to ensure that the
wording used in the questionnaire was correct and under-
stood by the target population. Most of the pilot tests
were performed by means of a postal questionnaire, re-
spondents were requested to mark every question or an-
swering category that they did not understand or found
hard to grasp and they were asked to provide suggestions
for improvement. Moreover, three think aloud pilot tests
were conducted to obtain more insight into how the re-
spondents approached answering the choice tasks. No
changes in the attributes and/or levels were deemed ne-
cessary based on the results of this pilot study. Moreover,
based on the pilot-test data, sample size calculations were
performed to ensure that significant differences for each
attribute could be detected at a 5% level [30,32].
Statistical analyses
NLogit 4.0 (Econometric Software, 2007) was used to
construct the panel-mixed-logit (Panel-MIXL) models
that were estimated within this study. When using suchiscrete choice experiment
Level 3
pect to improvements in their diet, developed by the participants
neral information on a
vides example recipes
Elaborate: a patient tailored schedule that is
completely prepared by the lifestyle coach
participants with respect to improvements in their PA behavior,
neral information on
ample exercises
Elaborate: a patient tailored schedule that is
completely prepared by the lifestyle coach
r T2DM patients Groups with 10 other T2DM patients
ness expected by the respondent after completion of a
ht lost and feeling 10 kilograms of weight lost and feeling
more healthy
sts out-of-pocket
225 euro per year
Table 3 Example of a choice task
Situation 1 Situation 2 None
Meal plan Flexible General None
Physical activity schedule General Elaborate None
Consultation structure Individual In groups of 5 patients None
Expected outcome 5 kg weight loss and feeling
more healthy
10 kg weight loss and feeling more
healthy
None
Out-of-pocket costs 150 euro per year 150 euro per year 0 euro per year
Tick the box of the situation that you prefer: 0 0 0
Veldwijk et al. BMC Public Health 2013, 13:1099 Page 5 of 8
http://www.biomedcentral.com/1471-2458/13/1099models, results are adjusted for the panel structure (i.e.,
multilevel structure) of the data. As every respondent
completed nine choice tasks, their answers may be cor-
related, which is then accounted for. Equation 1 was
tested using these models.
U ¼ V þ ε ¼ β0 þ β1  flexible meal planþ β2  elaborate meal plan
þ β3 flexible PA schedule þ β4  elaborate PA schedule
þ β5  consultation in groups of 5þ β6  consultation in groups of 10
þ β7  expected outcome þ β8  out of pocket costsþ ε
ð1Þ
V describes the measurable utility of a specific lifestyle
program based on the attributes that were included in
the DCE. β0 represents the alternative specific constant
and β1 – β8 are the attribute estimates that indicate the
relative importance of each attribute. Based on the model
fit (AIC and Chi-square tests), the constant and the ex-
pected outcome attributes were set as random parameters
(both with a normal distribution).
All nonlinear parameters were recorded into effect codes.
In contrast to dummy coding, this coding procedure codes
the reference category −1, so the sum of the effect coded
attributes is always 0. The coefficient for the reference cat-
egory is therefore −1*(βeffect code 1 + βeffect code 2) [33,34].
In order to calculate patients’ marginal willingness to
pay (WTP), the negative of the out-of-pocket attribute
was used as a measure of the marginal utility of money.
The ratio of either attribute estimate to this negative of
the out-of-pocket attribute provides an estimation of pa-
tients’ WTP concerning that specific attribute [28,35].
Moreover, the potential participation rates (choice prob-
abilities) of a program that consists of a specific set of at-
tributes was estimated. Since both the constant and the
expected outcome attribute were included as random pa-
rameters in the analyses, choice probabilities could not be
calculated directly, therefore a simulation was used [28,33].
The mean participation rates of all simulations (n = 1000)
were estimated by taking the average of all simulated
participation rate probabilities, which were calculated as
1/(1 + exp-v).For a more detailed description of the statistical methods
used in this paper see Additional file 2.Results
Patient preferences
Most of the attribute estimates were significant, indicat-
ing that they were important for T2DM patients when
choosing whether to participate in a lifestyle program
(Table 4). Participants did not have any distinct prefer-
ences with regard to the meal plan. However, they did
prefer a general PA schedule above a flexible PA schedule.
Participants reported a preference for individual consult-
ation, as compared to consultation in groups of 10 pa-
tients. The greater the expected outcome in terms of
weight loss, the more willing participants were to partici-
pate and higher out-of-pocket costs led to a decrease in
their willingness to participate.
Since the magnitude of the beta values depends
highly on the coding of the attributes, attributes were
recorded into the same coding scale (all attribute
levels were coded between −1 and 1) to enable the
assessment of their relative importance. The results of
the recoded analysis are not shown because they show
a high degree of overlap with the results presented in
Table 4 and provide betas that are difficult to interpret
especially concerning the outcome and costs attributes.
The results reveal that, based on the value of its coef-
ficient, the out-of-pocket costs were the most decisive
factor for respondents in determining whether they
wanted to participate in a lifestyle program. This attri-
bute was followed by the consultation structure and
expected outcome. The least important factor in the
decision-making process was the operationalization of
the PA schedule.
The significant coefficient of the standard deviation of
the expected outcome attribute indicates that there is in-
deed a high preference heterogeneity among respondents
concerning the amount of weight loss they anticipate be-
fore starting the intervention.
Finally, the opt-out option was chosen in 46.3% of the
choice tasks and 23.5% of the respondents chose to opt-
Table 4 T2DM patients’ preferences for a lifestyle program:
the attribute estimates of the Panel-MIXL model
Attribute Beta value SE
Constant Mean 0.11 0.13
Standard deviation 2.61* 0.71
Meal plan Flexible 0.11 0.07
General (ref) −0.04 0.06
Elaborate −0.06 0.06
PA schedule Flexible −0.13* 0.06
General (ref) 0.02 0.01
Elaborate 0.11 0.06
Consultation structure Individual (ref) 0.50 0.08
Groups of 5 −0.04 0.06
Groups of 10 −0.46*** 0.08
Expected outcome (10 kg) Mean 0.72*** 0.16
Standard deviation 1.53* 0.51
Out-of-pocket costs (€100) −0.75*** 0.08
*significant at p < .05; ***significant at p < .001.
Table 5 Expected participation rates for different lifestyle





Base model 48.5 A program with a general meal plan,
a flexible PA schedule, consultation in
groups of 10 and no weight loss
PA schedule 51.5 Base model with a general PA schedule
Consultation
structure




57.4 Base model with a 10 kg weight loss
Preferred
program
62.4 A program with a flexible meal plan,
a general PA schedule, individual
consultation and a 10 kg weight loss
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change when these latter responders were excluded from
the analysis.
Willingness to pay
The WTP was calculated for the significant attributes
only. The results show that respondents were willing to
pay €21.0 (95% CI: €11.3; €30.7) for a switch from a flex-
ible to a general PA schedule. Respondents were willing
to pay an extra €127.8 (95% CI: €106.0; €149.7) per year
for a lifestyle program organized via individual consult-
ation instead of consultation with a group of 10 other
patients. Respondents were willing to pay €96.8 (95% CI:
€85.2; €108.4) per year for 10 kg anticipated weight loss.
Potential participation rate
A lifestyle program that consists of all of the least pre-
ferred attribute levels (flexible meal plan, flexible PA
schedule, consultation in groups of 10, no weight loss)
was set as the ‘base’ model. This program showed the
lowest participation rate (48.5%) (Table 5). The potential
participation rate increased if this ‘base’ model was
adapted to the identified patient preferences (change to
51.5%-57.4%). The most preferred program, which in-
cludes a flexible meal plan, general PA schedule, individ-
ual consultation and a 10 kg weight loss, resulted in an
estimated potential participation rate of 62.4%.
Discussion
Our research is the first to demonstrate the relative im-
portance of the factors that affect T2DM patients’ prefer-
ences for a lifestyle intervention program. Results showed
that the out-of-pocket costs were the most crucial factorfor T2DM patients when deciding whether to participate
in a lifestyle program (i.e., patients preferred lowest costs).
Moreover, a lifestyle program with a general physical ac-
tivity component, individual consultation and large ex-
pected outcomes in terms of weight loss was preferred.
T2DM patients were willing to pay €21, €128 and €97 per
year respectively for a lifestyle program with these desired
levels of the attributes (i.e., a general PA schedule, individ-
ual consultation, and 10 kg anticipated weight loss). Add-
itionally, it was estimated that approximately 62% of the
T2DM patients aged 35–65 years would participate in a
lifestyle program with these preferred levels.
Though there is limited evidence regarding T2DM
patients’ preferences for a lifestyle program, the current
findings are comparable to those of previously con-
ducted DCEs among other target populations describing
different lifestyle interventions. The study by Johnson
[23] found that individuals at a high risk of developing
T2DM preferred a lifestyle program that specified antici-
pated weight loss over a program that did not describe
any anticipated weight loss. They also found that pro-
grams with restrictive diets were disliked, that some sort
of physical activity component was preferred, and that
the respondents were willing to pay up to approximately
$63 per month for a total of 36 months for participation
in the lifestyle program they preferred most [23]. Roux
and colleagues [25], as well as Owen and colleagues [24],
reported that participants in a lifestyle program preferred
personally oriented programs that included both a diet
and some sort of PA component. The diet component in
the program should not be too restrictive [24], and partici-
pants were willing to pay for participation [25].
Patients in the current study reported to be willing to pay
up to €97 per year for every 10 kilograms of anticipated
weight loss. Though this seems a promising argument to
boost participation without significantly increasing costs,
one could argue that, despite the linearity of the initial costs
and expected outcome attributes, beyond a certain point,
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for an increase of 10 kilograms of anticipated weight loss.
This was also shown by Johnson and colleagues who dem-
onstrated nonlinearity of the WTP [36].
Finally, results showed that a potential participation rate
of 62% can be expected when attributes are operational-
ized in accordance with patient preferences. Current
programs can be improved by organizing individual con-
sultation and communicating clearly about the anticipated
outcomes of the program (in terms of weight loss and
degree of physical fitness of the participant). The partici-
pation rates found in this study show that T2DM patients
are willing to participate if programs meet certain criteria.
However, the participation rates do not exceed the most
optimistic participation rates currently observed in life-
style programs [1,2,11]. This suggests that T2DM patients
have additional motives for not participating in a life-
style program other than the tested characteristics of a
lifestyle program. These motives may differ considerably
between individuals; previous research already sug-
gested tailored lifestyle programs to enhance patient
commitment [37,38]. Tailoring such programs to indi-
vidual patients can be costly and less feasible compared
to generic programs. It should be explored which fac-
tors, other than consultation structure and clear com-
munication with respect to expected outcomes, can be
maintained over the total target population in order to
limit the variation between programs and to keep costs
as low as possible while at the same time increasing pa-
tient commitment.
Our conclusions are restricted by a number of limita-
tions. The usable response rate was 31.3%. As the current
study was questionnaire-based and participation was on a
voluntary basis, selective non-response seems plausible. For
instance, the number of non-Dutch patients was relatively
low. This may be due to language difficulties, as a good
command of the Dutch language is needed to complete the
questionnaire and especially the DCE tasks. Therefore,
generalizability with regard to preferences of non-Dutch
patient groups remains limited. Besides, it could be the case
that patients who already perceive their lifestyle as being
healthy chose not to participate in this study. However, in
real life, it is not likely that these patients would participate
in a lifestyle program and therefore these patients are of
limited interest for this specific study.
The current study included T2DM patients in the age
group of 35–65 years, who do not suffer from severe
diabetes-related complications. There is limited informa-
tion on the representativeness of the current study popu-
lation compared to the target population. Additional
analyses of T2DM patients aged 35–65 in a large Dutch
cohort study (EPIC-NL [39]) showed the same mean BMI
values, but other characteristics could not be compared
because of the specific inclusion and exclusion criteria ofthe current study (in particular, the exclusion of patients
with severe diabetes-related complications in this study).
Future research should be conducted among T2DM pa-
tients aged > 65 years without any restrictions with respect
to the presence of diabetes-related complications to obtain
more insight into the preferences of this subpopulation.
Researchers should then take into account that the attri-
butes of the current DCE might not be applicable within
this new target population. Conducting such research
would contribute to the insights into (the differences and
similarities in) preferences of the entire T2DM patient
population with respect to lifestyle programs.
Conclusions
In conclusion, when deciding to participate in a lifestyle
program, T2DM patients in the age group of 35–65 years
are mostly driven by the out-of-pocket costs of a lifestyle
program, the structure of the consultation and the ex-
pected outcome of the program. We therefore advise that
lifestyle programs directed at T2DM patients should
be set up based on individual consultation, while commu-
nicating about the expected outcomes of the program
(in terms of weight loss) and keeping out-of-pocket costs
as limited as possible.
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Additional file 1: Detailed description of the additional
questionnaire. Here a detailed description is provided about the
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Additional file 2: Detailed description of the statistical methods.
Here a detailed description is provided about statistical background end
methods that were used for the analysis in this study.
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